Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection

CONCLUSIONS: SARS-CoV-2 infection is associated with elevated mortality in patients with cirrhosis. CLIF-C had better performance in predicting mortality than NACSELD, CTP and MELD-Na in patients with cirrhosis and SARS-CoV-2 infection. Clinicaltrials.gov:NCT04358380.PMID:33864948 | PMC:PMC8045426 | DOI:10.1016/j.aohep.2021.100350

Source: Annals of Hepatology - April 17, 2021 Category: Gastroenterology Authors: Manuel Mendizabal Ezequiel Ridruejo Federico Pi ñero Margarita Anders Mart ín Padilla Luis G Toro Aldo Torre Pedro Montes Alvaro Urz úa Esteban Gonzalez Ballerga Mar ía Dolores Silveyra Douglas Michelato Javier D íaz Mirta Peralta Josefina Pages Sand Source Type: research